CereGate Inc.
CereGate is dedicated to restoring and reimagining human senses through groundbreaking neurotechnology. Their hardware-agnostic computer-brain interface platform powers therapeutic solutions aimed at improving independence and quality of life for individuals with neurological disorders. With a focus on minimally invasive, scalable, and proven technology, CereGate collaborates with industry leaders and is advancing clinical trials to bring innovative treatments to market.
Industries
Nr. of Employees
small (1-50)
CereGate Inc.
Patents
On-line autocalibration method for a computer brain interface device and computer brain interface device
US-12214202-B2
View Details
On-line autocalibration method for a computer brain interface device and computer brain interface device
US-12214202-B2
View DetailsProducts
Hardware‑agnostic computer‑brain interface platform (software)
A modular software platform designed to communicate with approved neuromodulation implants to enable therapeutic and sensory applications without additional implants.
Hardware‑agnostic computer‑brain interface platform (software)
A modular software platform designed to communicate with approved neuromodulation implants to enable therapeutic and sensory applications without additional implants.
Services
Software integration services that enable information transmission and therapeutic control using existing implanted deep brain or spinal cord stimulators.
Design and execution support for human feasibility studies and clinical testing of CBI applications, including collaborations with clinical research groups.
Advisory and implementation capabilities for medical device quality systems (ISO 13485) and regulatory engagement including FDA pathways.
Software integration services that enable information transmission and therapeutic control using existing implanted deep brain or spinal cord stimulators.
Design and execution support for human feasibility studies and clinical testing of CBI applications, including collaborations with clinical research groups.
Advisory and implementation capabilities for medical device quality systems (ISO 13485) and regulatory engagement including FDA pathways.
Expertise Areas
- Computer‑brain interfaces
- Neuromodulation integration and repurposing
- Clinical trial conduct and human validation
- Neural signal processing and computational neurophysiology
Key Technologies
- Computer‑brain interface software
- Closed‑loop neuromodulation
- Spinal cord and deep brain stimulator interfacing
- Neural signal acquisition and processing
News & Updates
CereGate announces a peer-reviewed publication demonstrating the repurposing of spinal cord stimulators as computer-brain-interfaces capable of transmitting rhythmic cues, Morse code, and postural information, highlighting a significant advancement in neurotechnology.
Dr. Bálint Várkuti discusses neural interfaces, innovations, and future developments of CereGate in a podcast episode, including accessibility and scalability for broader applications.
CereGate demonstrates that existing spinal cord stimulators can be used as computer-brain-interfaces, capable of transmitting various signals and information, opening new possibilities in neurotechnology.
An interview with Dr. Várkuti on neural interfaces, innovations, and future plans of CereGate.
CereGate announces a peer-reviewed publication demonstrating the repurposing of spinal cord stimulators as computer-brain-interfaces capable of transmitting rhythmic cues, Morse code, and postural information, highlighting a significant advancement in neurotechnology.
Dr. Bálint Várkuti discusses neural interfaces, innovations, and future developments of CereGate in a podcast episode, including accessibility and scalability for broader applications.
CereGate demonstrates that existing spinal cord stimulators can be used as computer-brain-interfaces, capable of transmitting various signals and information, opening new possibilities in neurotechnology.
An interview with Dr. Várkuti on neural interfaces, innovations, and future plans of CereGate.